Effects of weekly bevacizumab and paclitaxel/carboplatin with or without sorafenib on heavily pretreated patients with recurrent or persistent cervical cancer.

5085 Background: Prognoses of patients with recurrent and metastatic cervical cancer (CC) who received treatment including radiotherapy are commonly dismal. In such clinical settings effective trea...